Skip to content

Study · Not a test of the peptide alone · 1995

2 results

The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches.

Anapliotou ML, Kastanias IT, Psara P, Evangelou EA, Liparaki M, Dimitriou P

Clinical endocrinology1 Mar 1995Cited by 81 (Europe PMC)

PMID7758233 (opens in a new tab)DOI10.1111/j.1365-2265.1995.tb01876.x (opens in a new tab)PepBankPUB-07758233
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking hCG (human chorionic gonadotropin).

  1. 01HumanNot a test of hCG (human chorionic gonadotropin) aloneNon-randomized trialEfficacy outcome

    In thalassaemia major, pooled continuous hormone replacement including male hCG increased BMD more than on/off courses.

    In plain wordsIn thalassaemia major, pooled continuous hormone replacement including male hCG increased bone density more than on/off courses.

    Peptide
    hCG (human chorionic gonadotropin)
    Outcome
    IncreaseBone mineral density increase
    Study

    n: not reported in source

    Comparator
    On/off treatment courses
    Outcome group
    Bone and joint · Musculoskeletal

    Measurements

    P value for BMD increase
    0.01 p value
    continuous replacement versus on/off treatment courses

    Source sentences

    Summary
    In the prospective study the continuous replacement group increased BMD and BMC values more than the on/off treatment courses (P = 0.01).
    2 context sentences
    Summary · context
    The continuous schemes comprised either transdermal oestradiol (100 micrograms) plus medroxyprogesterone for females or hCG to produce serum testosterone concentrations within normal range, for males.
    Summary · context
    Bone mineral density (BMD) and bone mineral content (BMC) of lumbar spine and distal end of radius were measured by dual-energy X-ray absorptiometry.

    In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking hCG (human chorionic gonadotropin).

  2. 02HumanNot a test of hCG (human chorionic gonadotropin) aloneNon-randomized trialEfficacy outcome

    In thalassaemia major, pooled continuous hormone replacement including male hCG increased BMC more than on/off courses.

    In plain wordsIn thalassaemia major, pooled continuous hormone replacement including male hCG increased bone mineral content more than on/off courses.

    Peptide
    hCG (human chorionic gonadotropin)
    Outcome
    IncreaseBone mineral content increase
    Study

    n: not reported in source

    Comparator
    On/off treatment courses
    Outcome group
    Bone and joint · Musculoskeletal

    Measurements

    P value for BMC increase
    0.01 p value
    continuous replacement versus on/off treatment courses

    Source sentences

    Summary
    In the prospective study the continuous replacement group increased BMD and BMC values more than the on/off treatment courses (P = 0.01).
    2 context sentences
    Summary · context
    The continuous schemes comprised either transdermal oestradiol (100 micrograms) plus medroxyprogesterone for females or hCG to produce serum testosterone concentrations within normal range, for males.
    Summary · context
    Bone mineral density (BMD) and bone mineral content (BMC) of lumbar spine and distal end of radius were measured by dual-energy X-ray absorptiometry.

    In this study, hCG (human chorionic gonadotropin) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking hCG (human chorionic gonadotropin).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.